BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 24, 2023

Oct. 24, 2023
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Blue Earth Diagnostics, Celltrion Group, Elevar Therapeutics, Fuji Pharma, GSK, Hansoh, Jiangsu Hengrui Pharmaceuticals, Mithra Pharmaceuticals, Sinotau Pharmaceutical.
Read More

Other news to note for Oct. 24, 2023

Oct. 24, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: BMS, Caris, Citius, Codagenix, Elektrofi, Eli Lilly, Gen1e, Harrow, Hyloris, Idorsia, Inimmune, Kye, Lianbio, Moderna, Neximmune, Ocean Medical, Siga, Tenx Keane, Theratechnologies.
Read More

Other news to note for Oct. 24, 2023

Oct. 24, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aktiia, Axosim, Vyant Bio, Butterfly Network, Forest Neurotech, Inspira Technologies, Xtant Medical, RTI Surgical.
Read More

Other news to note for Oct. 23, 2023

Oct. 23, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avenacy, Celltrion, Cybin, Erydel, Fuji, Mithra, Quince, Small.
Read More

Other news to note for Oct. 23, 2023

Oct. 23, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Elekta, Icad, Invo Bioscience, Naya Biosciences.
Read More

Other news to note for Oct. 23, 2023

Oct. 23, 2023
Additional early-stage research and drug discovery news in brief, from: Jaguar Health.
Read More

Other news to note for Oct. 20, 2023

Oct. 20, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Alaya.bio, Apotex, Biomarin, Calico, GSK, Hansoh, Laronde, Novartis, Sail, Senda, Teva.
Read More

Other news to note for Oct. 20, 2023

Oct. 20, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amwell, Bowflex, Elekta, Element Biosciences, Instat, Leidos, Massive Bio, Nautilus, Onocoassist, Oula, Revity, Surgical Theater, Veristat.
Read More

Other news to note for Oct. 20, 2023

Oct. 20, 2023
Additional early-stage research and drug discovery news in brief, from: GRI, Ionctura, Mymd.
Read More

Other news to note for Oct. 19, 2023

Oct. 19, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ayala, Basilea, Beam, Biosight, Eli Lilly, Geneuro, Gigagen, Gilead, Gravitas, Mablink, Microvascular, Oxford Nanopore, Pfizer, Qnovia, Seagen.
Read More
Previous 1 2 … 144 145 146 147 148 149 150 151 152 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing